| Product Code: ETC7421530 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Guyana Point of Care Testing (POCT) Market Overview |
3.1 Guyana Country Macro Economic Indicators |
3.2 Guyana Point of Care Testing (POCT) Market Revenues & Volume, 2021 & 2031F |
3.3 Guyana Point of Care Testing (POCT) Market - Industry Life Cycle |
3.4 Guyana Point of Care Testing (POCT) Market - Porter's Five Forces |
3.5 Guyana Point of Care Testing (POCT) Market Revenues & Volume Share, By Products, 2021 & 2031F |
3.6 Guyana Point of Care Testing (POCT) Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Guyana Point of Care Testing (POCT) Market Revenues & Volume Share, By Platform, 2021 & 2031F |
3.8 Guyana Point of Care Testing (POCT) Market Revenues & Volume Share, By Prescription Mode, 2021 & 2031F |
3.9 Guyana Point of Care Testing (POCT) Market Revenues & Volume Share, By Testing Type, 2021 & 2031F |
3.10 Guyana Point of Care Testing (POCT) Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.11 Guyana Point of Care Testing (POCT) Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Guyana Point of Care Testing (POCT) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in Guyana |
4.2.2 Growing demand for rapid and accurate diagnostic solutions |
4.2.3 Government initiatives to improve healthcare infrastructure in remote areas |
4.3 Market Restraints |
4.3.1 Lack of skilled healthcare professionals to operate point of care testing devices |
4.3.2 Limited awareness about the benefits of point of care testing among healthcare providers |
4.3.3 High cost associated with acquiring and maintaining point of care testing equipment |
5 Guyana Point of Care Testing (POCT) Market Trends |
6 Guyana Point of Care Testing (POCT) Market, By Types |
6.1 Guyana Point of Care Testing (POCT) Market, By Products |
6.1.1 Overview and Analysis |
6.1.2 Guyana Point of Care Testing (POCT) Market Revenues & Volume, By Products, 2021- 2031F |
6.1.3 Guyana Point of Care Testing (POCT) Market Revenues & Volume, By Glucose Monitoring Products, 2021- 2031F |
6.1.4 Guyana Point of Care Testing (POCT) Market Revenues & Volume, By Cardiometabolic Testing Products, 2021- 2031F |
6.1.5 Guyana Point of Care Testing (POCT) Market Revenues & Volume, By Infectious Diseases Testing Products, 2021- 2031F |
6.1.6 Guyana Point of Care Testing (POCT) Market Revenues & Volume, By Pregnancy and Fertility Testing Products, 2021- 2031F |
6.1.7 Guyana Point of Care Testing (POCT) Market Revenues & Volume, By Tumor/Cancer Marker Testing Products, 2021- 2031F |
6.1.8 Guyana Point of Care Testing (POCT) Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Guyana Point of Care Testing (POCT) Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Guyana Point of Care Testing (POCT) Market Revenues & Volume, By Blood Glucose Cardiac Monitoring, 2021- 2031F |
6.2.3 Guyana Point of Care Testing (POCT) Market Revenues & Volume, By Hematology, 2021- 2031F |
6.2.4 Guyana Point of Care Testing (POCT) Market Revenues & Volume, By Coagulation, 2021- 2031F |
6.2.5 Guyana Point of Care Testing (POCT) Market Revenues & Volume, By Whole Blood Analysis, 2021- 2031F |
6.2.6 Guyana Point of Care Testing (POCT) Market Revenues & Volume, By Vital Sign Monitoring, 2021- 2031F |
6.2.7 Guyana Point of Care Testing (POCT) Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Guyana Point of Care Testing (POCT) Market, By Platform |
6.3.1 Overview and Analysis |
6.3.2 Guyana Point of Care Testing (POCT) Market Revenues & Volume, By Lateral Flow Assays/Immunochromatography Tests, 2021- 2031F |
6.3.3 Guyana Point of Care Testing (POCT) Market Revenues & Volume, By Dipsticks, 2021- 2031F |
6.3.4 Guyana Point of Care Testing (POCT) Market Revenues & Volume, By Molecular Diagnostics, 2021- 2031F |
6.3.5 Guyana Point of Care Testing (POCT) Market Revenues & Volume, By Immunoassays, 2021- 2031F |
6.3.6 Guyana Point of Care Testing (POCT) Market Revenues & Volume, By Microfluidics, 2021- 2031F |
6.4 Guyana Point of Care Testing (POCT) Market, By Prescription Mode |
6.4.1 Overview and Analysis |
6.4.2 Guyana Point of Care Testing (POCT) Market Revenues & Volume, By Prescription Based Testing, 2021- 2031F |
6.4.3 Guyana Point of Care Testing (POCT) Market Revenues & Volume, By OTC Testing, 2021- 2031F |
6.5 Guyana Point of Care Testing (POCT) Market, By Testing Type |
6.5.1 Overview and Analysis |
6.5.2 Guyana Point of Care Testing (POCT) Market Revenues & Volume, By Immunoassays, 2021- 2031F |
6.5.3 Guyana Point of Care Testing (POCT) Market Revenues & Volume, By Cell-Based Assays, 2021- 2031F |
6.5.4 Guyana Point of Care Testing (POCT) Market Revenues & Volume, By Nucleic Acid Amplification Testing, 2021- 2031F |
6.5.5 Guyana Point of Care Testing (POCT) Market Revenues & Volume, By Clinical Chemistry Assays, 2021- 2031F |
6.5.6 Guyana Point of Care Testing (POCT) Market Revenues & Volume, By Hematology, 2021- 2031F |
6.6 Guyana Point of Care Testing (POCT) Market, By End-Users |
6.6.1 Overview and Analysis |
6.6.2 Guyana Point of Care Testing (POCT) Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 Guyana Point of Care Testing (POCT) Market Revenues & Volume, By Clinics, 2021- 2031F |
6.6.4 Guyana Point of Care Testing (POCT) Market Revenues & Volume, By Laboratories, 2021- 2031F |
6.6.5 Guyana Point of Care Testing (POCT) Market Revenues & Volume, By Home Care, 2021- 2031F |
6.6.6 Guyana Point of Care Testing (POCT) Market Revenues & Volume, By Ambulatory Surgical Centers, 2021- 2031F |
6.6.7 Guyana Point of Care Testing (POCT) Market Revenues & Volume, By Others, 2021- 2031F |
6.7 Guyana Point of Care Testing (POCT) Market, By Distribution Channel |
6.7.1 Overview and Analysis |
6.7.2 Guyana Point of Care Testing (POCT) Market Revenues & Volume, By Direct, 2021- 2031F |
6.7.3 Guyana Point of Care Testing (POCT) Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
7 Guyana Point of Care Testing (POCT) Market Import-Export Trade Statistics |
7.1 Guyana Point of Care Testing (POCT) Market Export to Major Countries |
7.2 Guyana Point of Care Testing (POCT) Market Imports from Major Countries |
8 Guyana Point of Care Testing (POCT) Market Key Performance Indicators |
8.1 Average turnaround time for test results |
8.2 Rate of adoption of point of care testing technologies in healthcare facilities |
8.3 Percentage of patients who receive timely treatment based on point of care test results |
9 Guyana Point of Care Testing (POCT) Market - Opportunity Assessment |
9.1 Guyana Point of Care Testing (POCT) Market Opportunity Assessment, By Products, 2021 & 2031F |
9.2 Guyana Point of Care Testing (POCT) Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Guyana Point of Care Testing (POCT) Market Opportunity Assessment, By Platform, 2021 & 2031F |
9.4 Guyana Point of Care Testing (POCT) Market Opportunity Assessment, By Prescription Mode, 2021 & 2031F |
9.5 Guyana Point of Care Testing (POCT) Market Opportunity Assessment, By Testing Type, 2021 & 2031F |
9.6 Guyana Point of Care Testing (POCT) Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.7 Guyana Point of Care Testing (POCT) Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Guyana Point of Care Testing (POCT) Market - Competitive Landscape |
10.1 Guyana Point of Care Testing (POCT) Market Revenue Share, By Companies, 2024 |
10.2 Guyana Point of Care Testing (POCT) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here